Rating Rationale
March 19, 2024 | Mumbai
Excel Industries Limited
Rating outlook revised to 'Negative'; Ratings Reaffirmed
 
Rating Action
Total Bank Loan Facilities RatedRs.149.5 Crore
Long Term RatingCRISIL A+/Negative (Outlook revised from 'Stable'; Rating Reaffirmed)
Short Term RatingCRISIL A1 (Reaffirmed)
Note: None of the Directors on CRISIL Ratings Limited’s Board are members of rating committee and thus do not participate in discussion or assignment of any ratings. The Board of Directors also does not discuss any ratings at its meetings.
1 crore = 10 million
Refer to Annexure for Details of Instruments & Bank Facilities

Detailed Rationale

CRISIL Ratings has revised its rating outlook on the long-term bank facilities of Excel Industries Ltd (EIL) to ‘Negative’ from ‘Stable’ and reaffirmed the rating at ‘CRISIL A+’. The short-term rating has been reaffirmed at ‘CRISIL A1’.

 

The revision in outlook follows a slower-than-expected ramp up in operational performance post a sharp deterioration in operational performance during the first nine months of fiscal 2024 (9MFY24). With the industry demand outlook likely to remain uncertain for the next couple of quarters, prolonged delay in recovery of operating performance would adversely impact the business risk profile of EIL even as its financial risk profile is expected to remain strong.

 

Revenue declined sharply by 31% in 9MFY24 to Rs 593 crore (9MFY23: Rs 864 crore),. The decline in revenue was majorly on account of steep fall in realisation both in the agro chemical and specialty chemical product groups owing to inventory corrections which has adversely impacted players in the chemical industry. Demand was also relatively muted especially in export regions such as the US and Europe due to overall slowdown in economy. As a result, exports declined by 50% to Rs 91 crore in 9MFY24 while domestic segment de-grew by 26% to Rs 502 crore (9MYF23: Rs.681 crore). Given steep decline in gross margins (by almost 300 basis points) in 9MFY24 to 38.5% (fiscal 2023: 42.05%) on account of inventory losses and loss of operating leverage, the company’s operating margin has declined significantly to 1.8% in 9MFY24 (fiscal 2023: 11.61%). Going forward, delay in recovery of operating performance could restrict improvement in the operating margin and adversely impact the business risk profile of the company.

 

However, the ratings continue to factor in the company’s established market position in the diethylthiophosphoryl chloride (DETC) segment and phosphonates product segment; presence in diversified customer segments, and geographies; and a strong financial risk profile because of healthy networth and debt protection metrics.

 

The financial risk profile remains comfortable, with strong networth of Rs 1,442 crore and a near debt-free balance sheet as on December 31, 2023. Total outside liabilities to tangible networth (TOL/TNW) ratio is expected to remain comfortable at below 0.3 time over the medium term. Cash surplus including liquid investments stood over Rs 200 crore (including short-term investments) as on December 31, 2023. Further, annual cash accrual -- expected at over Rs 85-100 crore per fiscal -- should be sufficient to meet capital expenditure (capex) and incremental working capital requirement. The company also has access to Rs 65 crore of unutilised fund-based bank limit, which provides added cushion. These strengths are partially offset by limited-yet-improving product diversity.

Analytical Approach

CRISIL Ratings has combined the business and financial risk profiles of EIL and its wholly owned subsidiaries -- Kamaljyot Investments Ltd and Excel Bio Resources Ltd. Goodwill worth Rs 18.85 crore on acquisition of the Visakhapatnam plant of Netmatrix Crop Care Ltd has been amortised for five years starting fiscal 2020.

 

Please refer Annexure - List of Entities Consolidated, which captures the list of entities considered and their analytical treatment of consolidation.

Key Rating Drivers & Detailed Description

Strengths:

  • Diversified revenue across end-user industries, customer segments, and geographies: The company started as an agrochemical intermediate manufacturer and has expanded its product portfolio over the years by leveraging its process chemistry capabilities in other segments, such as performance and speciality chemicals, polymer additives, and pharmaceutical inputs. Performance and speciality chemicals cater to diverse segments, such as soaps and detergents, water treatment, and paints and coating. The company has also presence in the polymer additives and pharmaceutical inputs segments to diversify revenue and reduce dependence on agrochemicals.

 

  • Comfortable financial risk profile: The capital structure remains comfortable, marked by healthy networth of Rs 1,442 crore as on December 31, 2023, due to steady accretion to reserve over the years and minimal debt. Absence of any large, debt-funded capex and prudent working capital management will enable low reliance on bank funding. Hence, the capital structure and debt protection metrics should remain strong over the medium term, with TOL/TNW ratio expected below 0.30 time over the medium term. This coupled with growing scale and improving profitability should further boost the financial risk profile.

 

Weaknesses:

  • High product concentration in revenue: DETC had about 40% share in overall revenue in fiscal 2023, which exposes the company to the inherent risk associated with price volatility determined by the supply situation in China. DETC is uses in making chlorpyrifos and profenofos, which are agrochemical technicals. The product concentration risk is however partially offset by the rising contribution from the non-agrochemical segment, which contributed to 40% of the revenue in fiscal 2023. Within the non-agrochemical segment, share of total revenue of phosphonates (key specialty chemical product) has been increasing steadily with recent capacity expansion in this segment. Any adverse regulatory decision or significant decline in prices of DETC may have a material impact on the performance of the company and will be a key monitorable.

 

  • Exposure to risks inherent in the agrochemical business: Revenue and profitability are susceptible to any unfavourable impact of government policies with respect to pollution control, product toxicity, or import and export of raw materials. The agrochemical revenue is also susceptible to vagaries of the monsoon. Though increasing focus on other segments should result in a more diversified revenue profile, and provide some cushion, revenue and profitability will be linked to these risks as a large part of income is derived from agrochemical intermediaries.

Liquidity: Strong

Cash surplus including liquid investments stood over Rs 200 crore (including short-term investments) as on December 31, 2023. Further, annual cash accrual -- expected at over Rs 85-100 crore per fiscal -- should be sufficient to meet capex and incremental working capital requirements. The company also has access to Rs 65 crore of unutilised fund-based bank limit, which provides added cushion.

Outlook: Negative

Operating performance of EIL is expected to remain subdued in the near to medium term, resulting in suboptimal cash generation. However, prudent working capital management, adequate cash surplus and unutilised bank lines will continue to support liquidity. 

Rating Sensitivity factors

Upward factors:

  • Sustained revenue growth, with material diversification in revenue profile; increase in share from specialty chemical/pharmaceutical/polymer divisions
  • Maintenance of operating margin over 14-15%, benefitting cash generation
  • Sustenance of healthy financial risk profile and improvement in liquidity

 

Downward factors:

  • Sustained decline in revenue with operating margin falling below 10%
  • Large, debt-funded capex or a sizeable stretch in the working capital cycle, increasing gearing to above 1 time

About the Company

Incorporated as a private-limited company in 1960, EIL was reconstituted into a public-limited company in 1971. Following the demerger of its crop protection business from its former associate, Excel Crop Care Ltd, EIL began manufacturing chemical intermediaries used in agrochemicals, commodity polymers, engineering polymers, soaps and detergents, water-treatment chemicals and biocides. The promoter group owned 52.60% stake in the company as on March 31, 2023.

Key Financial Indicators

As on/for the period ended March 31

Unit

2023

2022

Revenue

Rs.Crore

1,090

1,178

Profit After Tax (PAT)

Rs.Crore

76*

157*

PAT Margin

%

6.9

13.3

Adjusted gearing

Times

0.00

0.00

Interest coverage

Times

64.23

80.35

*Considering amortization of goodwill

Any other information: Not Applicable

Note on complexity levels of the rated instrument:
CRISIL Ratings` complexity levels are assigned to various types of financial instruments and are included (where applicable) in the 'Annexure - Details of Instrument' in this Rating Rationale.

CRISIL Ratings will disclose complexity level for all securities - including those that are yet to be placed - based on available information. The complexity level for instruments may be updated, where required, in the rating rationale published subsequent to the issuance of the instrument when details on such features are available.

For more details on the CRISIL Ratings` complexity levels please visit www.crisilratings.com. Users may also call the Customer Service Helpdesk with queries on specific instruments.

Annexure - Details of Instrument(s)

ISIN Name of the instrument Date of
Allotment		 Coupon
Rate (%)		 Maturity
Date		 Issue size
(Rs.Crore)		 Complexity
Level		 Rating assigned
with outlook
NA Cash credit* NA NA NA 65 NA CRISIL A+/Negative
NA Inland guarantees NA NA NA 3.5 NA CRISIL A1
NA Inland/Import Letter of Credit NA NA NA 41.5 NA CRISIL A1
NA Letter of credit/bank guarantee  NA NA NA 39.5 NA CRISIL A1

*Interchangeable with export packing credit, foreign bills discounting, and inland bills discounting

Annexure - List of Entities Consolidated

Names of Entities Consolidated

Extent of Consolidation

Rationale for Consolidation

Excel Bio Resources Ltd

Full

Wholly owned subsidiary

Kamaljyot Investments Ltd

Full

Wholly owned subsidiary
Annexure - Rating History for last 3 Years
  Current 2024 (History) 2023  2022  2021  Start of 2021
Instrument Type Outstanding Amount Rating Date Rating Date Rating Date Rating Date Rating Rating
Fund Based Facilities LT 65.0 CRISIL A+/Negative   -- 05-07-23 CRISIL A+/Stable 21-04-22 CRISIL A+/Positive 29-01-21 CRISIL A+/Stable / CRISIL A1 CRISIL A+/Stable / CRISIL A1
      --   --   --   --   -- CRISIL A1
Non-Fund Based Facilities ST 84.5 CRISIL A1   -- 05-07-23 CRISIL A1 21-04-22 CRISIL A1 29-01-21 CRISIL A1 CRISIL A1
All amounts are in Rs.Cr.
Annexure - Details of Bank Lenders & Facilities
Facility Amount (Rs.Crore) Name of Lender Rating
Cash Credit& 32.5 Bank of India CRISIL A+/Negative
Cash Credit& 22.75 State Bank of India CRISIL A+/Negative
Cash Credit& 9.75 Axis Bank Limited CRISIL A+/Negative
Inland Guarantees 1 State Bank of India CRISIL A1
Inland Guarantees 2.5 Bank of India CRISIL A1
Inland/Import Letter of Credit 6 Axis Bank Limited CRISIL A1
Inland/Import Letter of Credit 20 Bank of India CRISIL A1
Inland/Import Letter of Credit 15.5 State Bank of India CRISIL A1
Letter of credit & Bank Guarantee 22 Citibank N. A. CRISIL A1
Letter of credit & Bank Guarantee 17.5 HDFC Bank Limited CRISIL A1
&Interchangeable with export packing credit, foreign bills discounting, and inland bills discounting
Criteria Details
Links to related criteria
CRISILs Approach to Financial Ratios
Rating criteria for manufaturing and service sector companies
CRISILs Bank Loan Ratings - process, scale and default recognition
Rating Criteria for Chemical Industry
CRISILs Criteria for Consolidation
CRISILs Criteria for rating short term debt

Media Relations
Analytical Contacts
Customer Service Helpdesk

Aveek Datta
Media Relations
CRISIL Limited
M: +91 99204 93912
B: +91 22 3342 3000
AVEEK.DATTA@crisil.com

Prakruti Jani
Media Relations
CRISIL Limited
M: +91 98678 68976
B: +91 22 3342 3000
PRAKRUTI.JANI@crisil.com

Rutuja Gaikwad 
Media Relations
CRISIL Limited
B: +91 22 3342 3000
Rutuja.Gaikwad@ext-crisil.com


Anuj Sethi
Senior Director
CRISIL Ratings Limited
B:+91 44 6656 3100
anuj.sethi@crisil.com

Poonam Upadhyay
Director
CRISIL Ratings Limited
B:+91 22 3342 3000
poonam.upadhyay@crisil.com

Karthick G
Senior Rating Analyst
CRISIL Ratings Limited
B:+91 22 3342 3000
Karthick.G@crisil.com		Timings: 10.00 am to 7.00 pm
Toll free Number:1800 267 1301

For a copy of Rationales / Rating Reports:
CRISILratingdesk@crisil.com
 
For Analytical queries:
ratingsinvestordesk@crisil.com

 

Note for Media:
This rating rationale is transmitted to you for the sole purpose of dissemination through your newspaper/magazine/agency. The rating rationale may be used by you in full or in part without changing the meaning or context thereof but with due credit to CRISIL Ratings. However, CRISIL Ratings alone has the sole right of distribution (whether directly or indirectly) of its rationales for consideration or otherwise through any media including websites and portals.


About CRISIL Ratings Limited (A subsidiary of CRISIL Limited, an S&P Global Company)

CRISIL Ratings pioneered the concept of credit rating in India in 1987. With a tradition of independence, analytical rigour and innovation, we set the standards in the credit rating business. We rate the entire range of debt instruments, such as bank loans, certificates of deposit, commercial paper, non-convertible/convertible/partially convertible bonds and debentures, perpetual bonds, bank hybrid capital instruments, asset-backed and mortgage-backed securities, partial guarantees and other structured debt instruments. We have rated over 33,000 large and mid-scale corporates and financial institutions. We have also instituted several innovations in India in the rating business, including ratings for municipal bonds, partially guaranteed instruments and infrastructure investment trusts (InvITs).
 
CRISIL Ratings Limited ('CRISIL Ratings') is a wholly-owned subsidiary of CRISIL Limited ('CRISIL'). CRISIL Ratings Limited is registered in India as a credit rating agency with the Securities and Exchange Board of India ("SEBI").
 
For more information, visit www.crisilratings.com 
 



About CRISIL Limited

CRISIL is a leading, agile and innovative global analytics company driven by its mission of making markets function better. 

It is India’s foremost provider of ratings, data, research, analytics and solutions with a strong track record of growth, culture of innovation, and global footprint.

It has delivered independent opinions, actionable insights, and efficient solutions to over 100,000 customers through businesses that operate from India, the US, the UK, Argentina, Poland, China, Hong Kong and Singapore.

It is majority owned by S&P Global Inc, a leading provider of transparent and independent ratings, benchmarks, analytics and data to the capital and commodity markets worldwide.

For more information, visit www.crisil.com

Connect with us: TWITTER | LINKEDIN | YOUTUBE | FACEBOOK

CRISIL PRIVACY NOTICE
 
CRISIL respects your privacy. We may use your contact information, such as your name, address and email id to fulfil your request and service your account and to provide you with additional information from CRISIL. For further information on CRISIL's privacy policy please visit www.crisil.com.



DISCLAIMER

This disclaimer is part of and applies to each credit rating report and/or credit rating rationale ('report') that is provided by CRISIL Ratings Limited ('CRISIL Ratings'). To avoid doubt, the term 'report' includes the information, ratings and other content forming part of the report. The report is intended for the jurisdiction of India only. This report does not constitute an offer of services. Without limiting the generality of the foregoing, nothing in the report is to be construed as CRISIL Ratings providing or intending to provide any services in jurisdictions where CRISIL Ratings does not have the necessary licenses and/or registration to carry out its business activities referred to above. Access or use of this report does not create a client relationship between CRISIL Ratings and the user.

We are not aware that any user intends to rely on the report or of the manner in which a user intends to use the report. In preparing our report we have not taken into consideration the objectives or particular needs of any particular user. It is made abundantly clear that the report is not intended to and does not constitute an investment advice. The report is not an offer to sell or an offer to purchase or subscribe for any investment in any securities, instruments, facilities or solicitation of any kind to enter into any deal or transaction with the entity to which the report pertains. The report should not be the sole or primary basis for any investment decision within the meaning of any law or regulation (including the laws and regulations applicable in the US).

Ratings from CRISIL Ratings are statements of opinion as of the date they are expressed and not statements of fact or recommendations to purchase, hold or sell any securities/instruments or to make any investment decisions. Any opinions expressed here are in good faith, are subject to change without notice, and are only current as of the stated date of their issue. CRISIL Ratings assumes no obligation to update its opinions following publication in any form or format although CRISIL Ratings may disseminate its opinions and analysis. The rating contained in the report is not a substitute for the skill, judgment and experience of the user, its management, employees, advisors and/or clients when making investment or other business decisions. The recipients of the report should rely on their own judgment and take their own professional advice before acting on the report in any way. CRISIL Ratings or its associates may have other commercial transactions with the entity to which the report pertains.

Neither CRISIL Ratings nor its affiliates, third-party providers, as well as their directors, officers, shareholders, employees or agents (collectively, 'CRISIL Ratings Parties') guarantee the accuracy, completeness or adequacy of the report, and no CRISIL Ratings Party shall have any liability for any errors, omissions or interruptions therein, regardless of the cause, or for the results obtained from the use of any part of the report. EACH CRISIL RATINGS PARTY DISCLAIMS ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING BUT NOT LIMITED TO ANY WARRANTIES OF MERCHANTABILITY, SUITABILITY OR FITNESS FOR A PARTICULAR PURPOSE OR USE. In no event shall any CRISIL Ratings Party be liable to any party for any direct, indirect, incidental, exemplary, compensatory, punitive, special or consequential damages, costs, expenses, legal fees or losses (including, without limitation, lost income or lost profits and opportunity costs) in connection with any use of any part of the report even if advised of the possibility of such damages.

CRISIL Ratings may receive compensation for its ratings and certain credit-related analyses, normally from issuers or underwriters of the instruments, facilities, securities or from obligors. Public ratings and analysis by CRISIL Ratings, as are required to be disclosed under the regulations of the Securities and Exchange Board of India (and other applicable regulations, if any), are made available on its website, www.crisilratings.com (free of charge). Reports with more detail and additional information may be available for subscription at a fee - more details about ratings by CRISIL Ratings are available here: www.crisilratings.com.

CRISIL Ratings and its affiliates do not act as a fiduciary. While CRISIL Ratings has obtained information from sources it believes to be reliable, CRISIL Ratings does not perform an audit and undertakes no duty of due diligence or independent verification of any information it receives and/or relies on in its reports. CRISIL Ratings has established policies and procedures to maintain the confidentiality of certain non-public information received in connection with each analytical process. CRISIL Ratings has in place a ratings code of conduct and policies for managing conflict of interest. For details please refer to: https://www.crisil.com/en/home/our-businesses/ratings/regulatory-disclosures/highlighted-policies.html.

Rating criteria by CRISIL Ratings are generally available without charge to the public on the CRISIL Ratings public website, www.crisilratings.com. For latest rating information on any instrument of any company rated by CRISIL Ratings, you may contact the CRISIL Ratings desk at crisilratingdesk@crisil.com, or at (0091) 1800 267 1301.

This report should not be reproduced or redistributed to any other person or in any form without prior written consent from CRISIL Ratings.

All rights reserved @ CRISIL Ratings Limited. CRISIL Ratings is a wholly owned subsidiary of CRISIL Limited.
 

 

CRISIL Ratings uses the prefix 'PP-MLD' for the ratings of principal-protected market-linked debentures (PPMLD) with effect from November 1, 2011, to comply with the SEBI circular, "Guidelines for Issue and Listing of Structured Products/Market Linked Debentures". The revision in rating symbols for PPMLDs should not be construed as a change in the rating of the subject instrument. For details on CRISIL Ratings' use of 'PP-MLD' please refer to the notes to Rating scale for Debt Instruments and Structured Finance Instruments at the following link: https://www.crisil.com/en/home/our-businesses/ratings/credit-ratings-scale.html